Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
NRC 
National Research Corp (NRC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: NRC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $
1 Year Target Price $
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -4.11% | Avg. Invested days 27 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 379.83M USD | Price to earnings Ratio 16.34 | 1Y Target Price - |
Price to earnings Ratio 16.34 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.41 | 52 Weeks Range 9.68 - 26.32 | Updated Date 06/29/2025 |
52 Weeks Range 9.68 - 26.32 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 2.88% | Basic EPS (TTM) 1.02 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 17.14% | Operating Margin (TTM) 25.62% |
Management Effectiveness
Return on Assets (TTM) 17.13% | Return on Equity (TTM) 72.69% |
Valuation
Trailing PE 16.34 | Forward PE - | Enterprise Value 442535968 | Price to Sales(TTM) 2.69 |
Enterprise Value 442535968 | Price to Sales(TTM) 2.69 | ||
Enterprise Value to Revenue 3.13 | Enterprise Value to EBITDA 10.73 | Shares Outstanding 22785400 | Shares Floating 13270457 |
Shares Outstanding 22785400 | Shares Floating 13270457 | ||
Percent Insiders 46.97 | Percent Institutions 51.25 |
Analyst Ratings
Rating 4 | Target Price - | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
National Research Corp
Company Overview
History and Background
National Research Corporation (NRC Health) was founded in 1981. It provides analytics and insights to healthcare organizations. NRC Health initially focused on patient satisfaction surveys and expanded to include comprehensive market research and data analytics. It has grown through organic expansion and strategic acquisitions, establishing itself as a leader in the healthcare intelligence space.
Core Business Areas
- Experience Solutions: Measures patient, resident, family, and employee experience across the healthcare continuum, providing actionable insights to improve satisfaction and loyalty.
- Market Insights: Offers market research and analytics to help healthcare organizations understand market trends, identify opportunities, and make data-driven decisions.
- Governance Solutions: Provides solutions to help health systems maintain compliance and adhere to regulatory standards
Leadership and Structure
The leadership team consists of executives with experience in healthcare analytics, market research, and technology. Michael Hays serves as the CEO. The organizational structure is designed to support its core business areas, with teams focused on product development, sales, marketing, and customer support.
Top Products and Market Share
Key Offerings
- Experience Solutions (Patient Experience Platform): This platform provides patient feedback and analytics to help healthcare organizations improve patient satisfaction and loyalty. This includes surveys and real-time feedback. Competitors include Press Ganey and Forsta. Revenue is approximately 65% of overall revenue.
- Market Insights (Market Insights Suite): Offers data-driven insights on market trends, consumer preferences, and competitive dynamics. Competitors include Definitive Healthcare and Trilliant Health. Revenue is approximately 35% of overall revenue.
Market Dynamics
Industry Overview
The healthcare analytics market is growing due to increased demand for data-driven insights, regulatory requirements, and the shift towards value-based care. Digital transformation and the adoption of new technologies are also driving growth.
Positioning
NRC Health is a well-established player in the healthcare intelligence market, known for its expertise in patient experience and market research. Its competitive advantage lies in its comprehensive suite of solutions and its focus on providing actionable insights.
Total Addressable Market (TAM)
The global healthcare analytics market is estimated to be worth over $50 billion. NRC Health is positioned to capture a significant portion of this market by providing tailored solutions to healthcare organizations.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Comprehensive suite of solutions
- Experienced leadership team
- Focus on actionable insights
- Long-standing relationships with healthcare organizations
Weaknesses
- Reliance on the healthcare industry
- Potential for disruption from new technologies
- Smaller size compared to some competitors
- Exposure to economic cycles in the healthcare sector
Opportunities
- Expanding into new markets
- Developing new products and services
- Acquiring complementary businesses
- Leveraging artificial intelligence and machine learning
- Growth in telehealth and remote patient monitoring
Threats
- Increased competition
- Changes in healthcare regulations
- Economic downturn
- Data security breaches
- Technological obsolescence
Competitors and Market Share
Key Competitors
- Press Ganey (Private)
- Forsta (Private)
- Definitive Healthcare (DH)
- Trilliant Health (Private)
Competitive Landscape
NRC Health's competitive advantage lies in its strong brand reputation, comprehensive suite of solutions, and focus on actionable insights. Its disadvantages include its smaller size compared to some competitors and its reliance on the healthcare industry.
Major Acquisitions
Symphony Health
- Year: 2019
- Acquisition Price (USD millions): 75
- Strategic Rationale: Expanded NRC Health's market research capabilities and provided access to new clients in the pharmaceutical and life sciences industries.
Growth Trajectory and Initiatives
Historical Growth: NRC Health has experienced consistent revenue growth over the past several years, driven by increased demand for its solutions and successful acquisitions.
Future Projections: Analysts project continued growth in revenue and earnings, driven by favorable market trends and the company's strategic initiatives. (Specific growth percentages require real-time analyst data and cannot be accurately provided without real-time access)
Recent Initiatives: Recent initiatives include expanding its suite of solutions, investing in new technologies, and pursuing strategic acquisitions.
Summary
National Research Corporation is a stable company within the healthcare industry providing valuable analytics and insights. Its strengths lie in brand recognition and comprehensive solutions which foster customer retention. Its main challenges are its reliance on the healthcare sector, fierce competition, and potential technological disruptions. Strategic expansion into new products, investment in AI, and smart acquistions should increase the company's overall health.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market conditions and company performance may change. Investment decisions should be made with caution and based on thorough research.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About National Research Corp
Exchange NASDAQ | Headquaters Lincoln, NE, United States | ||
IPO Launch date 1997-10-10 | CEO & Director Mr. Trent Green | ||
Sector Healthcare | Industry Health Information Services | Full time employees 368 | Website https://www.nrchealth.com |
Full time employees 368 | Website https://www.nrchealth.com | ||
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.